Family and Coping Oriented Palliative Homecare Nursing Aimed at Advanced Cancer Patients (FamCope)
|ClinicalTrials.gov Identifier: NCT01444157|
Recruitment Status : Completed
First Posted : September 30, 2011
Last Update Posted : July 18, 2014
|Condition or disease||Intervention/treatment||Phase|
|Advanced Cancer||Other: Palliative homecare nursing||Phase 3|
Screening for patients will take place in the oncological, gynecological medical, surgical departments of three hospitals in Copenhagen, Denmark among patients diagnosed with cancer. Patients eligible for the study will be informed about the study during hospital admission and asked to participate together with a close relative/family member. When written informed consent has been obtained from both patient and relative they will be asked to fill in questionnaires with background information about sociodemographic data, their physical and psychosocial functioning and quality of life EORTC (QLQ-C30/patient and SF36/relative), their symptoms of anxiety and depression (HAD Scale/patient and relative) and family satisfaction with health care professionals(FamCare/relative). When patients have been discharge from hospital to their own home the families are randomized to control or intervention group. First visit from the research nurse takes place no later than one week after randomization. Visits takes place week 1,4,7,10,13 and 16 after randomization. The questionnaires EORTC QLQ-C30 (patient), HAD Scale (patient and relative), SF 36 (relative) and FamCare (relative) are mailed by post to the families to be answered at week 9, 16 and 24 after randomization. Information about the amount of care the family receives from the municipality (standard homecare) will be obtained from municipal registers. Information about readmissions to hospital are obtained from hospital registers.
The research nurses has a minimum of one year experience within specialised palliative care. The nurses has also participated in a two day course on how to produce and utilise family assessment and have been introduced to the background theory on coping and family nursing.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||700 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Family and Coping Oriented Palliative Homecare Nursing as a Supplement to Standard Homecare Nursing Aimed at Advanced Cancer Patients - a Randomized Intervention Trial|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||October 2013|
|Actual Study Completion Date :||April 2014|
Experimental: Palliative homecare nursing group
In addition to the standard homecare nursing the families will receive six home visits from a research nurse with at least 1 year specialised palliative care experience. During the first 2 hour visit a family assessment is obtained containing identification of family roles, resources and coping strategies. The first home visit takes place no later than one week after randomization. The visits continues every third week up to 16 weeks, each visit with a duration of 1,5 hours. At every visit the EORTC-QLQ-C30 patient administered questionnaire is used to identify the nature, frequency and intensity of the patients physical and psychosocial problems.
Other: Palliative homecare nursing
The nurse helps the family assess the identified problems. Written coping strategies according to each problem is produced including actions of the patient, family member, nurse or others. At the same time the nurse keeps attention to the family members specific needs of knowledge and support when handling direct or indirect care, understanding and coping with the disease, treatment, physical, psychosocial and economical problems and the family members own physical and mental health. The nurse provides knowledge to the family on how to prevent and/or cope with problems that may occur or re-occur and/or accepts or adapt to unsolvable problems.
No Intervention: Standard homecare nursing group
Patients continue to receive the standard homecare nursing. They can contact municipality services for visitation to homecare nursing if they feel that additional homecare is needed or if they do not yet receive this service and feel they need homecare nursing.
- Patient reported health related quality of life [ Time Frame: Baseline, week 9, week 16 and week 24 ]The change in mean scores from baseline to each follow up as measured in the Quality of life questionnaire EORTC QLQ-C30 scale score(Developed by the European Organization for Research and Treatment of Cancer)in relation to the Global health status scale.
- Patient reported symptoms and problems [ Time Frame: Baseline, week 9, week 16 and week 24 ]The change in mean scores from baseline to each follow up as measured in the EORTC QLQ-C30 questionnaire scale score in relation to its functional scales and symptom scales/items.
- Patients symptoms of anxiety and depression [ Time Frame: Baseline, week 9, week 16 and week 24 ]The change in mean scores from baseline to each follow up according to the HADS questionnaire (Hospital Anxiety and Depression Scale) Scores are self-reported.
- Family members symptoms of anxiety and depression [ Time Frame: Baseline, week 9, week 16, week 24 and 12 months ]The change in mean scores from baseline to each follow up according to the HADS questionnaire. Scores are self-reported.
- Family members health related quality of life [ Time Frame: Baseline, week 9, week 16, week 24 and 12 months ]The change in mean scores from baseline to each follow up. Scores are self-reported and measured in the SF36 v1 questionnaire.
- Family satisfaction with the health care services provided to the patient [ Time Frame: Baseline, week 9, week 16, week 24 and 12 months ]The change in mean scores from baseline to each follow up. Scores are self-reported and measured in the FAMCARE questionnaire
- Acute readmission to hospital [ Time Frame: week 16 and 24 ]The change in mean number of acute readmissions and mean period of hospitalizations (measured in days) from inclusion to the study to week 16 and 24. Readmissions must be related to the patients cancer disease
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01444157
|Copenhagen, Frederiksberg, Denmark, 2000|
|Copenhagen, NV, Denmark, 2400|
|Copenhagen, Denmark, 2100|
|Study Director:||Susan Rydahl Hansen, Cand.cur, PhD||Research Unit of Clinical Nursing, Bispebjerg Hospital|
|Principal Investigator:||Anne Birgitte Hjuler Ammari, Cand.scient.san||Research Unit of Clinical Nursing, Bispebjeg Hospital|